Image not available in RecallScope.
Losartan Potassium Tablets USP 50 mg 50 Tablets (5x10) Unit Dose boxes, Rx Only
Official notice
27 Mar 2019
An official FDA notice concerns Losartan Potassium Tablets USP 50 mg 50 Tablets (5x10) Unit Dose boxes, Rx Only. CGMP Deviations: presence of an impurity, N-Methylnitrosobutyric acid (NMBA) was identified Published 2019-03-27.
What to do now
This recall has been terminated. See the official FDA notice for the latest status.
Recall number
D-1044-2019
Official notice
2019-03-27
The hazard
The hazard
CGMP Deviations: presence of an impurity, N-Methylnitrosobutyric acid (NMBA) was identified
How to check if you’re affected
How to check if you’re affected
Compare the product name and identifiers below with the item you own. Check the official notice for the affected products and next steps.
Event Ids
Recall Numbers
Checked manually this time?
Follow brands and keywords in the app to receive alerts for matching official notices.
Turn on recall alertsAffected products
Affected products
Product 1
Hazard
Where it was sold
Where it was sold
Retailer information is not currently available in RecallScope. Check the official notice for distribution details.
Location 1
Affected area 1
Company & contacts
Company & contacts
Brand: Avkare. Contact: AVKARE Inc..
Source & status
Source & status
Recall details
Recall details
Recall number
Event ID
Status
Source tier
Documents, notices & source
See the official notice and source documents for full details.
View full official noticeWeekly recall digest
Get next week’s recalls before you need them.
One email every Monday with official-source recalls for your country, and nothing else. Unsubscribe from any email.
The digest arrives once a week. For matching recall alerts after notices are processed, get the app.